Which menopause telehealth subscription is cheapest?

Evernow and the Alloy symptom-evaluation tier both list $49/month. Evernow includes FDA-approved HRT at that price, while the Alloy $49 tier is evaluation-only — a prescription moves it to $99/month. The lowest true total cost is often an insurance-billing platform when your plan is in-network.

Do menopause subscriptions include the medication cost?

Some do and some do not. Evernow and Winona bundle FDA-approved HRT into the monthly fee. Alloy includes a prescription at the $99 tier but bills add-ons separately, and Hers ships medications billed separately by formulation. Always check whether the quoted price is medication-inclusive.

Can I pause a menopause telehealth subscription?

Most cash-pay platforms let you pause or cancel between refills. If you are on a stable regimen, some patients switch to a per-visit or insurance-billing model to avoid paying a monthly fee during periods when they do not need active dose management.

Are these subscriptions HSA/FSA-eligible?

Yes. Cash-pay telehealth subscriptions and consultations are HSA/FSA-eligible with itemized receipts that identify the medical service performed.

Cost & insurance review · Updated July 2026

How much does a menopause telehealth subscription cost?

Medically reviewed by Editorial Medical Review, MD, NAMS-CMP

Quick answer

$49-$99/mo. Cash-pay menopause telehealth subscriptions cluster around $49-$99/month in 2026. Evernow lists $49/month (consult plus FDA-approved HRT), Alloy Womens Health charges $49/month for symptom evaluation or $99/month with an HRT prescription, Winona starts around $70/month with medication included, and Hers Menopause runs about $99/month. Insurance-billing platforms like Midi Health are not flat subscriptions — they bill visits to commercial insurance with $25-$50 copays instead.

Price ranges by tier

What each pricing tier includes, sourced from manufacturer pricing pages, Cost Plus Drugs, KFF, LillyDirect, and NovoCare.

Evernow subscription

$49/mo

Clinician consult
FDA-approved HRT medication included
Message-based follow-ups

Alloy — symptom evaluation only

$49/mo

Perimenopause and menopause symptom review
Async clinician messaging
No prescription included at this tier

Alloy — with HRT prescription

$99/mo

Unlimited async clinician messaging
HRT prescription included
Labs, testosterone, vaginal estrogen billed separately

Winona subscription

From ~$70/mo

Clinician consult
FDA-approved HRT medication shipped monthly

Hers Menopause subscription

~$99/mo

Async clinician consult and prescription
HRT medications shipped and billed separately by formulation

Insurance-billing platform (Midi Health)

$25-$50 copay/visit

Not a flat subscription — bills commercial insurance
Cash-pay alternative: $150-$300 initial, $99 follow-up

Factors that affect cost

Whether the subscription bundles medication or bills it separately
Symptom-evaluation-only tier vs prescription-inclusive tier (e.g. Alloy $49 vs $99)
Whether the platform bills insurance (Midi) or is cash-pay only (Alloy, Evernow, Winona, Hers)
Add-ons: labs, testosterone therapy, and vaginal estrogen are often billed on top
Annual vs monthly billing — some platforms discount prepaid annual plans
Pausing or cancelling between refills if you are on a stable regimen

Insurance context

Most menopause telehealth subscriptions (Alloy, Evernow, Winona, Hers) are cash-pay and do not bill insurance directly, though they issue itemized receipts for HSA/FSA reimbursement. Insurance-billing platforms such as Midi Health are not flat subscriptions — they bill commercial insurance and Medicare with standard specialist copays. The FDA-approved medications prescribed can often be filled at an in-network pharmacy and billed to insurance even when the visit itself is cash-pay.

Financial help options

HSA/FSA accounts: Cover cash-pay subscription fees and telehealth visits with itemized receipts identifying the medical service.
Fill medication through insurance separately: Even on a cash-pay subscription, an FDA-approved HRT prescription can often be filled at an in-network pharmacy and billed to insurance — sometimes cheaper than a medication-inclusive plan.
Compare subscription vs per-visit: Two cash-pay visits per year (about $198) can beat a $49/month subscription ($588/year) if you are on a stable regimen and do not need active dose management.
Insurance-billing platforms: Midi Health and similar platforms bill commercial insurance with $25-$50 copays — often the lowest total cost when the plan is in-network.
FQHC sliding-scale (in-person alternative) ↗: For income-eligible patients: $25-$80 per visit plus HRT prescribing at a federally-qualified health center.

Related brands

Editorial cross-links only — no affiliate CTAs. Follow each link for our full brand review, formulary, and clinician model.

Frequently asked questions

Which menopause telehealth subscription is cheapest?: Evernow and the Alloy symptom-evaluation tier both list $49/month. Evernow includes FDA-approved HRT at that price, while the Alloy $49 tier is evaluation-only — a prescription moves it to $99/month. The lowest true total cost is often an insurance-billing platform when your plan is in-network.
Do menopause subscriptions include the medication cost?: Some do and some do not. Evernow and Winona bundle FDA-approved HRT into the monthly fee. Alloy includes a prescription at the $99 tier but bills add-ons separately, and Hers ships medications billed separately by formulation. Always check whether the quoted price is medication-inclusive.
Can I pause a menopause telehealth subscription?: Most cash-pay platforms let you pause or cancel between refills. If you are on a stable regimen, some patients switch to a per-visit or insurance-billing model to avoid paying a monthly fee during periods when they do not need active dose management.
Are these subscriptions HSA/FSA-eligible?: Yes. Cash-pay telehealth subscriptions and consultations are HSA/FSA-eligible with itemized receipts that identify the medical service performed.

Sources

Every pricing figure is sourced from public manufacturer pages, Cost Plus Drugs, KFF, or FDA data. External links open in a new tab.